Viatris Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.68, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Viatris Inc in Jun 30 2026 quarter, has decreased to 78 days, compared to 80 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 335 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1456 to 2354.

What is Receivable Turnover Ratio?
What is Viatris Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VTRS Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-4.05 %	-1.58 %	-5.9 %	-9.3 %	-8.66 %
Y / Y Revenue Change	4.88 %	8.07 %	4.97 %	0.23 %	-5.65 %
Receivable Turnover Ratio (TTM)	4.68	4.57	4.47	4.35	4.24
VTRS's Total Ranking	# 2354	# 1456	# 2132	# 2049	# 1503
Accounts Receivable average collection period days	78	80	82	84	86
Seq. Receivable Change	1.62 %	1.48 %	-10.09 %	3.48 %	4.24 %
Seq. Revenue Change	6.82 %	-5.04 %	-1.5 %	4.96 %	10.07 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 94
Healthcare Sector	# 336
Overall Market	# 2354

Receivable Turnover Ratio Statistics
High	Average	Low
0.5	0.35	0.31
(Jun 30 2021)		(Dec 31 2021)

News about Viatris Inc Receivables Turnover Ratios

Navigating Financial Straits Viatris Inc.s Improving Receivables Amidst Sector Challenges,

Navigating Financial Straits: Viatris Inc. s Improving Receivables Amidst Sector Challenges In the fast-evolving landscape of pharmaceutical sciences, fiscal resilience stands as a paramount pillar for sustained success. Viatris Inc. (NASDAQ: VTRS), a notable player in this realm, has recently been spotlighted with significant financial developments that warrant attention from its shareholders and the wider investment community. As April 2025 unfolds, an important notice from The Gross Law Firm serves as a clarion call to those vested in Viatris, urging them to deliberate over their rights before the looming deadline of June 3, 2025.At the heart of this narrative lies Viatris’ capacity to manage its accounts receivable, particularly from its corporate clients a key indicator of its fiscal health and operational efficiency. In the fourth quarter of 2024, the company demonstrated a noteworthy improvement in its ability to collect outstanding accounts receivable, with the collection ratio rising to 4.17. Although this figure falls below the company’s historical average, it offers a beacon of cautious optimism amidst a challenging business environment.

VTRS Company Profile • Back to VTRS Efficiency Comparisons • Compare VTRS Receivables Turnover Ratio to its Competitors

Financial Statements
Viatris Inc 's Accounts Receivable	$ 3,126 Millions	Visit VTRS's Balance sheet
Viatris Inc 's Sales TTM	$ 14,737 Millions	Visit VTRS's Income Statement
Sources of VTRS's Revenues		Visit VTRS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VTRS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VTRS's Growth Rates	VTRS's Roa	VTRS's Inventory Turnover Ratio	VTRS's Dividend Comparisons
VTRS's Profitability Ratios	VTRS's Roi	VTRS's Asset Turnover Ratio	VTRS's Dividend Growth
VTRS's Valuation Ratios	VTRS's Roe	VTRS's Financial Strength Ratios	VTRS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Teladoc Health Inc	11.74	$ 2,489.480 Millions	$ 212.023 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Irhythm Holdings Inc	10.32	$ 825.702 Millions	$ 80.007 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Biodesix Inc	10.21	$ 102.939 Millions	$ 10.081 Millions
Viemed Healthcare Inc	10.18	$ 301.606 Millions	$ 29.637 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
United Therapeutics Corporation	9.93	$ 3,154.500 Millions	$ 317.550 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions

Date modified: 2026-09-12T06:24:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.